FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060368510> ?p ?o ?g. }

• W2060368510 endingPage "36" @default.
• W2060368510 startingPage "23" @default.
• W2060368510 abstract "3-Deoxyglucosone (3-DG) is synthesized via the Maillard reaction and the polyol pathway, and is detoxified to 3-deoxyfructose and 2-keto-3-deoxygluconic acid. 3-DG rapidly reacts with protein amino groups to form advanced glycation end products (AGEs) such as imidazolone, pyrraline, N'-(carboxymethyl)lysine and pentosidine, among which imidazolone is the AGE most specific for 3-DG. As demonstrated by using gas chromatography-mass spectrometry or high-performance liquid chromatography, plasma 3-DG levels are markedly increased in diabetes and uremia. Although the plasma 3-DG levels had been controversial, it was clearly demonstrated that its plasma level depends on the deproteinization method by which either free or total 3-DG, presumably bound to proteins, is measured. In diabetes, hyperglycemia enhances the synthesis of 3-DG via the Maillard reaction and the polyol pathway, and thereby leads to its high plasma and erythrocyte levels. In uremia, however, the decreased catabolism of 3-DG, which may be due to the loss of 3-DG reductase activity in the end-stage kidneys, may lead to high plasma 3-DG level. The elevated 3-DG levels in plasma and erythrocytes may promote the formation of AGEs such as imidazolone, as demonstrated by immunohistochemistry and immunochemistry using an anti-imidazolone antibody. Although AGE-modified proteins prepared in vitro exhibit a variety of biological activities, known AGE structures have not yet been demonstrated to show any biological activities. Because 3-DG is potent in the formation of AGEs and has some biological activities, such as cellular toxicity, it may be more important in the development of diabetic and uremic complications than the known AGE structures. By demonstrating that treatment with an aldose reductase inhibitor reduces the erythrocyte levels of 3-DG and AGEs, such as imidazolone, light is shed on the mystery of how aldose reductase inhibitors may prove beneficial in diabetic complications. These evidences suggest that 3-DG plays a principal role in the development of diabetic and uremic complications." @default.
• W2060368510 created "2016-06-24" @default.
• W2060368510 creator A5035153820 @default.
• W2060368510 date "1999-08-01" @default.
• W2060368510 modified "2023-10-01" @default.
• W2060368510 title "3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication" @default.
• W2060368510 cites W1532082751 @default.
• W2060368510 cites W1542598870 @default.
• W2060368510 cites W1557253076 @default.
• W2060368510 cites W1608261530 @default.
• W2060368510 cites W1676406316 @default.
• W2060368510 cites W170700958 @default.
• W2060368510 cites W1912317501 @default.
• W2060368510 cites W1964435353 @default.
• W2060368510 cites W1966428143 @default.
• W2060368510 cites W1973251040 @default.
• W2060368510 cites W1976068063 @default.
• W2060368510 cites W1981099064 @default.
• W2060368510 cites W1981944005 @default.
• W2060368510 cites W1982749310 @default.
• W2060368510 cites W1983367107 @default.
• W2060368510 cites W1986791036 @default.
• W2060368510 cites W1992380863 @default.
• W2060368510 cites W1992592000 @default.
• W2060368510 cites W1996337164 @default.
• W2060368510 cites W1998498936 @default.
• W2060368510 cites W2000896479 @default.
• W2060368510 cites W2001348757 @default.
• W2060368510 cites W2002260554 @default.
• W2060368510 cites W2003391895 @default.
• W2060368510 cites W2006739782 @default.
• W2060368510 cites W2007172328 @default.
• W2060368510 cites W2010686055 @default.
• W2060368510 cites W2010754688 @default.
• W2060368510 cites W2018108565 @default.
• W2060368510 cites W2019970574 @default.
• W2060368510 cites W2023863634 @default.
• W2060368510 cites W2025008758 @default.
• W2060368510 cites W2026782054 @default.
• W2060368510 cites W2028008593 @default.
• W2060368510 cites W2030249540 @default.
• W2060368510 cites W2036699544 @default.
• W2060368510 cites W2038516205 @default.
• W2060368510 cites W2040005689 @default.
• W2060368510 cites W2042641359 @default.
• W2060368510 cites W2048501962 @default.
• W2060368510 cites W2052219353 @default.
• W2060368510 cites W2057539684 @default.
• W2060368510 cites W2059185726 @default.
• W2060368510 cites W2059409739 @default.
• W2060368510 cites W2065012620 @default.
• W2060368510 cites W2074246342 @default.
• W2060368510 cites W2075065472 @default.
• W2060368510 cites W2075879120 @default.
• W2060368510 cites W2077411395 @default.
• W2060368510 cites W2078382140 @default.
• W2060368510 cites W2079428613 @default.
• W2060368510 cites W2080904568 @default.
• W2060368510 cites W2081089294 @default.
• W2060368510 cites W2091960651 @default.
• W2060368510 cites W2094317381 @default.
• W2060368510 cites W2098692284 @default.
• W2060368510 cites W2104584816 @default.
• W2060368510 cites W2108586702 @default.
• W2060368510 cites W2109277179 @default.
• W2060368510 cites W2126346844 @default.
• W2060368510 cites W2164553737 @default.
• W2060368510 cites W2168994316 @default.
• W2060368510 cites W2315500707 @default.
• W2060368510 cites W2325494555 @default.
• W2060368510 cites W2356626379 @default.
• W2060368510 cites W4214620135 @default.
• W2060368510 cites W4253962687 @default.
• W2060368510 cites W4301077605 @default.
• W2060368510 cites W87434055 @default.
• W2060368510 doi "https://doi.org/10.1016/s0378-4347(99)00113-9" @default.
• W2060368510 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10491986" @default.
• W2060368510 hasPublicationYear "1999" @default.
• W2060368510 type Work @default.
• W2060368510 sameAs 2060368510 @default.
• W2060368510 citedByCount "127" @default.
• W2060368510 countsByYear W20603685102012 @default.
• W2060368510 countsByYear W20603685102013 @default.
• W2060368510 countsByYear W20603685102014 @default.
• W2060368510 countsByYear W20603685102015 @default.
• W2060368510 countsByYear W20603685102016 @default.
• W2060368510 countsByYear W20603685102017 @default.
• W2060368510 countsByYear W20603685102018 @default.
• W2060368510 countsByYear W20603685102019 @default.
• W2060368510 countsByYear W20603685102020 @default.
• W2060368510 countsByYear W20603685102021 @default.
• W2060368510 countsByYear W20603685102022 @default.
• W2060368510 countsByYear W20603685102023 @default.
• W2060368510 crossrefType "journal-article" @default.
• W2060368510 hasAuthorship W2060368510A5035153820 @default.
• W2060368510 hasConcept C126322002 @default.
• W2060368510 hasConcept C136502266 @default.
• W2060368510 hasConcept C147990577 @default.

• next